🇺🇸 FDA
Patent

US 10988458

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

granted A61PA61P1/16A61P3/00

Quick answer

US patent 10988458 (Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P1/16, A61P3/00, A61P9/00